Trends in Acute Ischemic Stroke Trials Through the 20th Century
- 1 June 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (6) , 1349-1359
- https://doi.org/10.1161/01.str.32.6.1349
Abstract
Background and Purpose—The advent of controlled clinical trials revolutionized clinical medicine over the course of the 20th century. The objective of this study was to quantitatively characterize ...Keywords
This publication has 30 references indexed in Scilit:
- Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled TrialJAMA, 1998
- What Questions Can Large, Simple Trials Answer?Cerebrovascular Diseases, 1998
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokePublished by Elsevier ,1997
- Thirty years of medical research council randomized trials in solid tumoursClinical Oncology, 1997
- Recently Developed Neuroprotective Therapies for Acute StrokeCNS Drugs, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcomeThe Lancet, 1993
- Publication bias in clinical researchThe Lancet, 1991
- Meta‐analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co‐operative trialsStatistics in Medicine, 1987